Point72 Asset Management, L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:10 pm Sale | 2024-12-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 9,986,132 8.700% | -5,130,364 (-33.94%) | Filing |
| 2024-11-14 7:59 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 15,116,496 9.900% | 9,872,873 (+188.28%) | Filing |
| 2024-02-14 4:11 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 5,243,623 6.100% | 1,680,721 (+47.17%) | Filing |
| 2023-06-01 5:00 pm Purchase | 2023-05-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 3,562,902 5.000% | 3,562,902 (New Position) | Filing |